Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.

The objective of this study was to assess the contributions of surfactant-mediated solubility and micellar diffusivity on the ability of surfactant to enhance drug dissolution. The following model was derived to predict the degree to which surfactants enhance griseofulvin dissolution: phi = 1 + (fm/ff).((D(D-M)2/3)/(DD2/3)) where phi is the degree of surfactant-mediated dissolution enhancement, fm is the fraction of the drug in micelle, and ff is the fraction of free drug, and DD and D(D-M) are the diffusivities of free drug and drug-loaded micelles, respectively. The Wood apparatus was used to measure the dissolution of griseofluvin in the presence of the anionic surfactant sodium dodecyl sulfate (SDS), the cationic surfactant cetyl trimethyl ammonium bromide (CTAB), and the neutral surfactants Tween 80 and Cremophor EL. DD was estimated using the Levich equation. D(D-M) was measured using dynamic light scattering. Griseofulvin solubility was evaluated in SDS, CTAB, Tween 80, and Cremophor EL at the surfactant concentrations used in the dissolution studies. DD was 11.0 x 10(-6) cm2/s. D(D-M) was 1.29 x 10(-6) cm2/s, 0.956 x 10(-6) cm2/s, 0.569 x 10(-6) cm2/s, and 0.404 x 10(-6) cm2/s for griseofulvin-loaded micelles of SDS, CTAB, Tween 80, and Cremophor EL, respectively. At the highest surfactant concentrations studied, griseofulvin solubility increased 107-fold, 31-fold, fourfold, and threefold for SDS, CTAB, Tween 80, and Cremophor EL. Dissolution into SDS and CTAB were markedly enhanced, but only about one-third as much as solubility enhancement. Dissolution enhancement in the presence of SDS and CTAB were in excellent agreement with model predicted values, with prediction error less than 12%. The model predicted dissolution into Tween 80 and Cremophor EL to be minimally enhanced, as was observed, although the model underpredicted dissolution into these two neutral surfactants. The derived model predicted surfactant-mediated dissolution and reflects dissolution enhancement to be promoted by surfactant-enhanced solubility, but limited by the relatively slow diffusion of drug-loaded surfactant micelles.

[1]  E. Townley,et al.  Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data. , 1970, Journal of pharmaceutical sciences.

[2]  P. Luner,et al.  Wetting behavior of bile salt-lipid dispersions and dissolution media patterned after intestinal fluids. , 2001, Journal of pharmaceutical sciences.

[3]  N. Kaniwa,et al.  Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate. , 1982, Journal of pharmaceutical sciences.

[4]  G. McClelland,et al.  The Use of Pharmacoscintigraphy to Elucidate Food Effects Observed with a Novel Protease Inhibitor (Saquinavir) , 1998, Pharmaceutical Research.

[5]  N. Muhammad,et al.  Evaluation and Selection of Bio-relevant Dissolution Media for a Poorly Water-Soluble New Chemical Entity , 2001, Pharmaceutical development and technology.

[6]  M. Gibaldi,et al.  Mechanisms of surfactant effects on drug absorption. , 1970, Journal of pharmaceutical sciences.

[7]  S. Riegelman,et al.  Absorption characteristics of solid dispersed and micronized griseofulvin in man. , 1971, Journal of pharmaceutical sciences.

[8]  Vinod P. Shah,et al.  In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants , 1989, Pharmaceutical Research.

[9]  Antonioli Ja.  Intestinal absorption of drugs , 1969 .

[10]  D. Crommelin,et al.  Dissolution kinetics of griseofulvin in sodium dodecylsulphate solutions. , 1987, Journal of pharmaceutical sciences.

[11]  Alexander T. Florence,et al.  Physicochemical Principles of Pharmacy , 1988 .

[12]  J. Dressman,et al.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  H. Zia,et al.  Chromatographic analysis of griseofulvin and metabolites in biological fluids. , 1980, Journal of chromatography.

[14]  D. Storey,et al.  Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent. , 1999, International journal of pharmaceutics.

[15]  Koji Takahashi,et al.  Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[16]  K. J. Child,et al.  Human blood griseofulvin levels from different dosage schedules. , 1962, Antibiotics & chemotherapy.

[17]  C. Larive,et al.  A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions. , 1997, Journal of pharmaceutical sciences.

[18]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[19]  D. Crommelin,et al.  Intestinal Absorption of Drugs. The Influence of Mixed Micelles on on the Disappearance Kinetics of Drugs from the Small Intestine of the Rat , 1991, The Journal of pharmacy and pharmacology.

[20]  J. Polli,et al.  Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system. , 1999, International journal of pharmaceutics.

[21]  G. J. Morris,et al.  Fluid and Particle Laser Doppler Velocity Measurements and Mass Transfer Predictions for the Usp Paddle Method Dissolution Apparatus , 1990 .

[22]  W. Higuchi,et al.  Mechanistic study of the influence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs. , 1968, Journal of pharmaceutical sciences.

[23]  B. Abrahamsson,et al.  Evaluation of Solubilizers in the Drug Release Testing of Hydrophilic Matrix Extended-Release Tablets of Felodipine , 1994, Pharmaceutical Research.

[24]  J. Polli,et al.  Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. , 1997, Journal of pharmaceutical sciences.

[25]  J. Dressman,et al.  Comparison of the Mechanism of Dissolution of Hydrocortisone in Simple and Mixed Micelle Systems , 1993, Pharmaceutical Research.

[26]  N. Kaniwa,et al.  Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets. , 1982, Journal of pharmacobio-dynamics.

[27]  J. Gregory,et al.  Dosage form and formulation effects on the bioavailability of vitamin E, riboflavin, and vitamin B-6 from multivitamin preparations. , 1987, The American journal of clinical nutrition.

[28]  Andrew L. Rukhin,et al.  Tools for statistical inference , 1991 .

[29]  Nicholas J. Turro,et al.  Luminescent probes for detergent solutions. A simple procedure for determination of the mean aggregation number of micelles , 1978 .

[30]  Tapan Sanghvi,et al.  Solubilization and preformulation of carbendazim. , 2002, International journal of pharmaceutics.

[31]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[32]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[33]  J. Crison,et al.  Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine. , 1996, Journal of pharmaceutical sciences.

[34]  R. Borchardt,et al.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.